 |
| Heather Bresch |
She recently justified the cost increase on the U.S. health care system citing price markups of the multiple layers of distribution players.
Before I set forth a series of poignant questions which, as a CEO, she failed to raise, I would like everyone to watch this video on the cost of the EpiPen in Canada. International distribution did not change pricing.
Now, here are my questions for the U.S. Senate Judiciary Committee and Chairman Chuck Grassley:
(Q1) Why was the announcement to raise the price made the same day Bresch made $5 million in selling off her stock of Mylan, knowing fully well, in advance, the schedule of her option was also set for the same day?
(A1) This action was obviously strategic, but why? At this juncture one can only guess, but I am going for the maximization of profits for "tax aversion" purposes, of course.
(Q2) Why, as an issue of corporate ethics, in the light of the Shrkeli price gouging of Daraprim scandal, would such a person take such a similar action, knowing fully well, that the targeted population are children of poverty, specifically public schools, with unfunded mandates, to be stocked with necessary medicine, billed through Medicaid?
(A2) Medicaid fraud in child welfare is an unregulated industry, pervasively woven into the fabric our national history, with no elected officials, public administrators or anyone from the legal or child welfare community willing to speak upon these well documented woes. I assert, that, because the industry is too big to fail and the profits will eventually fund political campaigns to keep the system intact, no one will initiate movement in fear of the destruction of one's political career.
(Q3) Has this woman, with her father a prominent Senator Joe Manchin, taken a backdoor political stance with him on the repeal of Obamacare by blaming Obamacare for the price hike in order for her father to keep his Democratic seat in the Senate in a strongly Republican-swayed presidential 2016 district made by the salacious actions of the DNC?
(A3) Sounds plausible to me.
(Q4) Is there a possible, spurious, relationship between the inversion of Mylar and the Clinton Foundation?
(A4) Only a formal referral for federal investigation can answer this question.
(Q5) Could this possibly be a violation of antitrust? Let me sniff.
(A5) Yup. It stinks of antitrust violations. Seek and ye shall find, my fine Senate Judiciary Staffers!
"Get 'em."
Senate Judiciary Chair Chuck Grassley Request to Heather Bresch of Mylan on EpiPen Price Increase by Beverly Tran on Scribd
#epigate #epipen
Voting is beautiful, be beautiful ~ vote.©
No comments:
Post a Comment